Company Filing History:
Years Active: 2023
Title: Benoit Vanhollebeke: Innovator in Neurovascular Therapeutics
Introduction
Benoit Vanhollebeke is a notable inventor based in Auderghem, Belgium. He has made significant contributions to the field of neurovascular disorders through his innovative research and patenting efforts. His work focuses on developing novel therapeutic agents that can activate specific signaling pathways crucial for treating central nervous system disorders.
Latest Patents
Benoit holds a patent for "Wnt7 variants capable of activating g-protein coupled receptor (Gpr)124/Reck/frizzled/lipoprotein receptor-related protein (LRP)-mediated Wnt signaling." This patent describes agents that can activate GPR124/RECK/Frizzled/LRP-mediated Wnt signaling without triggering Frizzled/LRP-mediated Wnt signaling in the absence of RECK and/or GPR124. These agents are particularly useful for the prevention or treatment of neurovascular dysfunction and other central nervous system disorders. He has 1 patent to his name.
Career Highlights
Benoit Vanhollebeke is affiliated with the Université Libre de Bruxelles, where he conducts his research. His work has garnered attention for its potential impact on therapeutic strategies for neurovascular and CNS disorders. His innovative approach to activating specific signaling pathways has positioned him as a key figure in this area of research.
Conclusion
Benoit Vanhollebeke's contributions to the field of neurovascular therapeutics highlight the importance of innovation in addressing complex medical challenges. His patented work offers promising avenues for the treatment of neurovascular disorders, showcasing the vital role of inventors in advancing healthcare solutions.